Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects

Phase 2 Unknown 28 enrolled Shanghai AbelZeta Ltd. Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · collab

RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of ReJoinTM for the Knee Osteoarthritis patients with Cartilage Defects comparing to Sodium Hyaluronate Injection.

Timeline

Start: 2014-07
Primary completion: 2019-12
Completion: 2019-12

Publications

Qiao Z, Tang J, Yue B, Wang J, Zhang J, Xuan L, Dai C, Li S, Li M, Xu C, Dai K, Wang Y. Human adipose-derived mesenchymal progenitor cells plus microfracture and hyaluronic acid for cartilage repair: a Phase IIa trial. Regen Med. 2020 Jan;15(1):1193-1214. doi: 10.2217/rme-2019-0068. Epub 2020 Feb 11.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ReJoinTM	Unknown	—	Other
Comparator	Sodium Hyaluronate	Other / unclassified	—	Other

Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects

Summary

Timeline

Publications

Drugs

Indications